Jaguar Health Statistics

Total Valuation

Jaguar Health has a market cap or net worth of $3.38 million. The enterprise value is $46.47 million.

Market Cap	3.38M
Enterprise Value	46.47M

Important Dates

The last earnings date was Tuesday, April 7, 2026, before market open.

Earnings Date	Apr 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Jaguar Health has 14.04 million shares outstanding. The number of shares has increased by 691.90% in one year.

Current Share Class	14.04M
Shares Outstanding	14.04M
Shares Change (YoY)	+691.90%
Shares Change (QoQ)	+250.21%
Owned by Insiders (%)	6.62%
Owned by Institutions (%)	3.80%
Float	13.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.33
Forward PS	0.21
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.50

Current Ratio	0.50
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-673.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-61.46%
Return on Invested Capital (ROIC)	-80.07%
Return on Capital Employed (ROCE)	1,935.14%
Weighted Average Cost of Capital (WACC)	0.58%
Revenue Per Employee	$244,915
Profits Per Employee	-$1.14M
Employee Count	47
Asset Turnover	0.25
Inventory Turnover	0.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.79% in the last 52 weeks. The beta is 0.29, so Jaguar Health's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-97.79%
50-Day Moving Average	0.49
200-Day Moving Average	1.34
Relative Strength Index (RSI)	26.10
Average Volume (20 Days)	611,009

Short Selling Information

The latest short interest is 599,897, so 4.27% of the outstanding shares have been sold short.

Short Interest	599,897
Short Previous Month	481,255
Short % of Shares Out	4.27%
Short % of Float	4.57%
Short Ratio (days to cover)	1.21

Income Statement

In the last 12 months, Jaguar Health had revenue of $11.51 million and -$53.58 million in losses. Loss per share was -$22.97.

Revenue	11.51M
Gross Profit	7.74M
Operating Income	-45.11M
Pretax Income	-54.00M
Net Income	-53.58M
EBITDA	-43.20M
EBIT	-45.11M
Loss Per Share	-$22.97

Full Income Statement

Balance Sheet

The company has $968,000 in cash and $43.61 million in debt, giving a net cash position of -$42.64 million or -$3.04 per share.

Cash & Cash Equivalents	968,000
Total Debt	43.61M
Net Cash	-42.64M
Net Cash Per Share	-$3.04
Equity (Book Value)	-18.69M
Book Value Per Share	-2.83
Working Capital	-20.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.69 million and capital expenditures -$41,000, giving a free cash flow of -$23.73 million.

Operating Cash Flow	-23.69M
Capital Expenditures	-41,000
Depreciation & Amortization	1.91M
Net Borrowing	12.69M
Free Cash Flow	-23.73M
FCF Per Share	-$1.69

Full Cash Flow Statement

Margins

Gross Margin	67.21%
Operating Margin	-391.87%
Pretax Margin	-469.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Jaguar Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-691.90%
Shareholder Yield	-691.90%
Earnings Yield	-1,397.00%
FCF Yield	-618.69%

Analyst Forecast

The average price target for Jaguar Health is $60.00, which is 24,796.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$60.00
Price Target Difference	24,796.27%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date	Mar 24, 2025
Split Type	Reverse
Split Ratio	1:25

Scores

Jaguar Health has an Altman Z-Score of -18.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.77
Piotroski F-Score	3